Additionally, although we stimulated fibroblasts and promoted their activation using IGF1 in vitro, in vivo inhibition of IGF will be needed to evaluate whether the transition from AKI to CKD is prevented. This evidence concerns the gene IGF1 and chronic kidney disease.